UNLABELLED: In an attempt to explore infectious agents associated with nasopharyngeal carcinomas (NPCs), we employed our high-throughput RNA sequencing (RNA-seq) analysis pipeline, RNA CoMPASS, to investigate the presence of ectopic organisms within a number of NPC cell lines commonly used by NPC and Epstein-Barr virus (EBV) researchers. Sequencing data sets from both CNE1 and HONE1 were found to contain reads for human papillomavirus 18 (HPV-18). Subsequent real-time reverse transcription-PCR (RT-PCR) analysis on a panel of NPC cell lines identified HPV-18 in CNE1 and HONE1 as well as three additional NPC cell lines (CNE2, AdAH, and NPC-KT). Further analysis of the chromosomal integration arrangement of HPV-18 in NPCs revealed patterns identical to those observed in HeLa cells. Clustering based on human single nucleotide variation (SNV) analysis of two separate HeLa cell lines and several NPC cell lines demonstrated two distinct clusters with CNE1, as well as HONE1 clustering with the two HeLa cell lines. In addition, duplex-PCR-based genotyping showed that CNE1, CNE2, and HONE1 do not have a HeLa cell-specific L1 retrotransposon insertion, suggesting that these three HPV-18(+) NPC lines are likely products of a somatic hybridization with HeLa cells, which is also consistent with our RNA-seq-based gene level SNV analysis. Taking all of these findings together, we conclude that a widespread HeLa contamination may exist in many NPC cell lines, and authentication of these cell lines is recommended. Finally, we provide a proof of concept for the utility of an RNA-seq-based approach for cell authentication. IMPORTANCE: Nasopharyngeal carcinoma (NPC) cell lines are important model systems for analyzing the complex life cycle and pathogenesis of Epstein-Barr virus (EBV). Using an RNA-seq-based approach, we found HeLa cell contamination in several NPC cell lines that are commonly used in the EBV and related fields. Our data support the notion that contamination resulted from somatic hybridization with HeLa cells, likely occurring at the point of cell line establishment. Given the rarity of NPCs, the long history of NPC cell lines, and the lack of rigorous cell line authentication, it is likely that the actual prevalence and impact of HeLa cell contamination on the EBV field might be greater. We therefore recommend cell line authentication prior to performing experiments using NPC cell lines to avoid inaccurate conclusions. The novel RNA-seq-based cell authentication approach reported here can serve as a comprehensive method for validating cell lines.

Department of Medicine Section of Gastroenterology Tulane University School of Medicine New Orleans Louisiana USA

Graduate School of Pharmaceutical Sciences Hokkaido University Sapporo Hokkaido Japan

Sun Yat Sen University Cancer Center Guangzhou People's Republic of China

Tulane University Health Sciences Center and Tulane Cancer Center New Orleans Louisiana USA

Zobrazit více v PubMed

Chang ET, Adami H-O. 2006. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15:1765–1777. 10.1158/1055-9965.EPI-06-0353 PubMed DOI

Shanmugaratnam K, Sobin L. 1993. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 71:2689–2697 PubMed

Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. 2008. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int. J. Cancer 123:2105–2112. 10.1002/ijc.23685 PubMed DOI PMC

Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100. 10.1126/science.1152586 PubMed DOI PMC

Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22:299–306. 10.1101/gr.126516.111 PubMed DOI PMC

Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22:292–298. 10.1101/gr.126573.111 PubMed DOI PMC

Lin Z, Puetter A, Coco J, Xu G, Strong MJ, Wang X, Fewell C, Baddoo M, Taylor C, Flemington EK. 2012. Detection of murine leukemia virus in the Epstein-Barr virus-positive human B-cell line JY, using a computational RNA-Seq-based exogenous agent detection pipeline, PARSES. J. Virol. 86:2970–2977. 10.1128/JVI.06717-11 PubMed DOI PMC

Strong MJ, O'Grady T, Lin Z, Xu G, Baddoo M, Parsons C, Zhang K, Taylor CM, Flemington EK. 2013. Epstein-Barr virus and human herpesvirus 6 detection in a non-Hodgkin's diffuse large B-cell lymphoma cohort by using RNA sequencing. J. Virol. 87:13059–13062. 10.1128/JVI.02380-13 PubMed DOI PMC

Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong AL, Lehman TA, Seddon MB, Lin Z, Concha M, Baddoo M, Ferris M, Swan KF, Sullivan DE, Burow ME, Taylor CM, Flemington EK. 2013. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog. 9:e1003341. 10.1371/journal.ppat.1003341 PubMed DOI PMC

Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D, Taylor CM, Flemington EK. 2013. Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J. Virol. 87:1172–1182. 10.1128/JVI.02517-12 PubMed DOI PMC

Lin Z, Xu G, Deng N, Taylor C, Zhu D, Flemington EK. 2010. Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells. J. Virol. 84:13053–13058. 10.1128/JVI.01521-10 PubMed DOI PMC

Xu G, Strong MJ, Lacey MR, Baribault C, Flemington EK, Taylor CM. 2014. RNA CoMPASS: a dual approach for pathogen and host transcriptome analysis of RNA-Seq datasets. PLoS One 9:e89445. 10.1371/journal.pone.0089445 PubMed DOI PMC

LTVCI. 1978. Establishment of an epithelioid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma. Sci. Sin. 21:127–134 PubMed

Gu SU, Tann BF, Zeng Y, Zhou WP, Li K, Zhao MC. 1983. Establishment of an epithelial cell line (CNE-2) from an NPC patient with poorly differentiated squamous cell carcinoma. Chin. J. Cancer 2:70–72

Takimoto T, Furukawa M, Hatano M, Umeda R. 1984. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Ann. Otol. Rhinol. Laryngol. 93:166–169 PubMed

Takimoto T, Kamide M, Umeda R. 1984. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT). Arch. Otorhinolaryngol. 239:87–92. 10.1007/BF00454266 PubMed DOI

Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. 1989. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 86:9524–9528. 10.1073/pnas.86.23.9524 PubMed DOI PMC

Cheung ST, Huang DP, Hui ABY, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JCK. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83:121–126. 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F PubMed DOI

Gey G, Coffman W, Kubicek M. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264–265

Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, Pääbo S, Mann M. 2011. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7:548. 10.1038/msb.2011.81 PubMed DOI PMC

Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. 2011. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25:1915–1927. 10.1101/gad.17446611 PubMed DOI PMC

Nix D, Courdy S, Boucher K. 2008. Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics 9:523. 10.1186/1471-2105-9-523 PubMed DOI PMC

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403–410 PubMed

Pruitt KD, Tatusova T, Brown GR, Maglott DR. 2012. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 40:D130–D135. 10.1093/nar/gkr1079 PubMed DOI PMC

Huson DH, Mitra S, Ruscheweyh H-J, Weber N, Schuster SC. 2011. Integrative analysis of environmental sequences using MEGAN4. Genome Res. 21:1552–1560. 10.1101/gr.120618.111 PubMed DOI PMC

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. 10.1093/bioinformatics/bts635 PubMed DOI PMC

Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24–26. 10.1038/nbt.1754 PubMed DOI PMC

Li B, Dewey CN. 2011. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. 10.1186/1471-2105-12-323 PubMed DOI PMC

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078–2079. 10.1093/bioinformatics/btp352 PubMed DOI PMC

Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. 2012. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568–576. 10.1101/gr.129684.111 PubMed DOI PMC

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559–575. 10.1086/519795 PubMed DOI PMC

Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, McVean G, Durbin R, 1000 Genomes Project Analysis Group 2011. The variant call format and VCFtools. Bioinformatics 27:2156–2158. 10.1093/bioinformatics/btr330 PubMed DOI PMC

R Core Team. 2014. R: a language and environment for statistical computing. R. Foundation for Statistical Computing, Vienna, Austria: URL http://www.R-project.org/

Kreimer AR, Clifford GM, Boyle P, Franceschi S. 2005. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14:467–475. 10.1158/1055-9965.EPI-04-0551 PubMed DOI

Adey A, Burton JN, Kitzman JO, Hiatt JB, Lewis AP, Martin BK, Qiu R, Lee C, Shendure J. 2013. The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 500:207–211. 10.1038/nature12064 PubMed DOI PMC

Yoshida A, Watanabe S, Gartler SM. 1971. Identification of HeLa cell glucose 6-phosphate dehydrogenase. Biochem. Genet. 5:533–539. 10.1007/BF00485671 PubMed DOI

Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C, Badge RM. 2009. A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques 46:277–284 PubMed PMC

Singhi AD, Califano J, Westra WH. 2012. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 34:213–218. 10.1002/hed.21714 PubMed DOI

Cayrol C, Flemington EK. 1996. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:2748–2759 PubMed PMC

Liao JY, Ma LM, Guo YH, Zhang YC, Zhou H, Shao P, Chen YQ, Qu LH. 2010. Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3′ trailers. PLoS One 5:e10563. 10.1371/journal.pone.0010563 PubMed DOI PMC

Chan SY-Y, Choy K-W, Tsao S-W, Tao Q, Tang T, Chung GT-Y, Lo K-W. 2008. Authentication of nasopharyngeal carcinoma tumor lines. Int. J. Cancer 122:2169–2171. 10.1002/ijc.23374 PubMed DOI

American Type Culture Collection Standards Development Organization Workgroup ASN-0002. 2010. Cell line misidentification: the beginning of the end. Nat. Rev. Cancer 10:441–448. 10.1038/nrc2852 PubMed DOI

Masters JR. 2002. HeLa cells 50 years on: the good, the bad and the ugly. Nat. Rev. Cancer 2:315–319. 10.1038/nrc775 PubMed DOI

Rojas A, Gonzalez I, Figueroa H. 2008. Cell line cross-contamination in biomedical research: a call to prevent unawareness. Acta Pharmacol. Sin. 29:877–880. 10.1111/j.1745-7254.2008.00809.x PubMed DOI

Lacroix M. 2008. Persistent use of “false” cell lines. Int. J. Cancer 122:1–4. 10.1002/ijc.23233 PubMed DOI

Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer